Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study

By Tang Thomas   Glanville Julie   Hayden Catherine J.   White Davinia   Barth Julian H.   Balen Adam H.  

Human Reproduction, Vol. 21, Iss. 1, 2006-01 ,pp. : 80-89

Oxford University Press

Access to resources Recommend Favorite

A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination

By Palomba Stefano  

Human Reproduction, Vol. 20, Iss. 10, 2005-10 ,pp. : 2879-2886

Oxford University Press

Access to resources Recommend Favorite

Reproductive endocrinology. Effects of metformin on ovulation rate, hormonal and metabolic profiles in women with clomiphene-resistant polycystic ovaries: a randomized, double-blinded placebo-controlled trial

By Ng Ernest Hung Yu   Wat Nelson Ming Sun  

Human Reproduction, Vol. 16, Iss. 8, 2001-08 ,pp. : 1625-1631

Oxford University Press

Access to resources Recommend Favorite

Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study

By Sahin I   Serter R   Karakurt F   Demirbas B   Culha C   Taskapan C   Kosar F   Aral Y  

Gynecological Endocrinology, Vol. 19, Iss. 3, 2004-09 ,pp. : 115-124

Informa Healthcare

Access to resources Recommend Favorite

Low-dose pioglitazone, flutamide, metformin plus an estro-progestagen for non-obese young women with polycystic ovary syndrome: increasing efficacy and persistent safety over 30 months

By Ibáñez Lourdes   López-bermejo Abel   Díaz Marta   Enríquez Goya   Del Río Luis   De Zegher Francis  

Gynecological Endocrinology, Vol. 26, Iss. 12, 2010-12 ,pp. : 869-873

Informa Healthcare

Access to resources Recommend Favorite